Breaking News, Collaborations & Alliances

Antiverse Alliance Aims to Iidentify Antibody Drug Candidates using AI

Demonstrates potential of Antiverse’s platform to reduce time and costs associated with antibody drug discovery.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Antiverse, a biotechnology company developing a computational antibody drug discovery platform, partnered with a top 20 pharma company in the life science fields of health care and nutrition. The collaboration has been successful in identifying antibody candidates for a target of interest, with greater diversity (2.3x) and accuracy compared to alternative bioinformatics pipeline selection methods.   Using Antiverse’s proprietary AI-Augmented Drug Discovery platform, 248 sequences were identifi...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters